1. Home
  2. Labeler Index
  3. Eugia Us Llc
  4. 55150-272
  5. Product Images: Cyclophosphamide

Product Images Cyclophosphamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Cyclophosphamide NDC 55150-272 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 500 mg per 2.5 mL (200 mg per mL) - Container Label - cyclophosphamide fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 500 mg per 2.5 mL (200 mg per mL) - Container Label - cyclophosphamide fig1

Cyclophosphamide is a medication that is administered via injection. Each 2.5 mL of the injection contains 500 mg of Cyclophosphamide (200 mg per mL). It is intended for intravenous use after dilution and is labeled as a hazardous agent. The vial is sterile and nonpyrogenic. Each mL of the injection also contains 4 mg of citric acid dissolved in dehydrated alcohol (0.676 g). The recommended dosage should be determined based on the prescribing information. The vial should be stored refrigerated at a temperature between 2°C to 8°C (36°F to 46°F). The medication is manufactured in India for Eugia US LLC, with a location in E. Windsor, NJ.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-500 mg per 2.5 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-500 mg per 2.5 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 1 g per 5 mL (200 mg per mL) - Container Label - cyclophosphamide fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 1 g per 5 mL (200 mg per mL) - Container Label - cyclophosphamide fig3

This is a description for a medication called Cyclophosphamide, which is available in a sterile and nonpyrogenic form. It is intended for intravenous use after dilution. The medication is a hazardous agent and comes in a multiple-dose vial. Each mL of the solution contains 200 mg of Cyclophosphamide and 4 mg of citric acid dissolved in dehydrated alcohol. The recommended dosage should be obtained from the prescribing information. The vial should be stored refrigerated at 2°C to 8°C. The medication is manufactured in India for M Eugia US LLC, located in Windsor, NJ.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1 g per 5 mL (200 mg per mL) - - cyclophosphamide fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1 g per 5 mL (200 mg per mL) - - cyclophosphamide fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-2 g per 10 mL (200 mg per mL) - Container Label - cyclophosphamide fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-2 g per 10 mL (200 mg per mL) - Container Label - cyclophosphamide fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-2 g per 10 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-2 g per 10 mL (200 mg per mL) - Container-Carton (1 Vial) - cyclophosphamide fig6

cyclophosphamide-structure - cyclophosphamide str

cyclophosphamide-structure - cyclophosphamide str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.